NOTE

🌱 created from: multiple myeloma (MM)

bispecific_antibodies_for_relapse_and_refractory_multiple_myeloma

bite_rrmm

• Triple Class and Penta Refracotry MM: Poor outcomes in relapse and refractory MM
• MAMMOTH study
• Current BsAb options in MM are:
  • BCMA, GPRC5D
  • MajesTEC-1
  • MagnetisMM-3